An array of both existing and investigational biologic agents are showing efficacy in clearing psoriasis and may prove useful for long-term psoriasis management. So suggests a collection of studies presented at the 60th annual meeting of the American Academy of Dermatology, held recently in New Orleans.
New indication: Biologic cleared for psoriatic arthritis
NME: Topical nonsteroid for second-line eczema Tx
Health plans demand more information to gauge real value of new pharmaceuticals.
New Indication: Oral contraceptive approved for acne
Forget the taboo. Sexually transmitted diseases are costing American employers just as much as more socially acceptable medical conditions. A panel of experts from the public and private sectors suggests actions.
Outside activities are lots of fun, to be sure, but also potentially expensive for employers because of increased medical and other costs due to skin cancer?the most common form of cancer in the United States.
